Growth Metrics

Whitehawk Therapeutics (WHWK) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -10.84%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 26.38%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -46.86%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.80%
7 Evaxion A 62.56 Bn 62.54 Bn - 34.98%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -3.84%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 47.10%
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - -13.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -13.39%
Dec 31, 2025 101.97%
Sep 30, 2025 -6.93%
Jun 30, 2025 -42.42%
Mar 31, 2025 93.71%
Dec 31, 2024 -4.55%
Sep 30, 2024 47.58%
Jun 30, 2024 -49.00%
Mar 31, 2024 -60.28%
Dec 31, 2023 -59.12%
Sep 30, 2023 -77.99%
Jun 30, 2023 -57.91%
Mar 31, 2023 -57.20%
Dec 31, 2022 -46.27%
Sep 30, 2022 -46.03%
Jun 30, 2022 -47.58%
Mar 31, 2022 -17.73%
Dec 31, 2021 -23.36%
Sep 30, 2021 -112.15%
Jun 30, 2021 9.72%
Mar 31, 2021 15.74%
Dec 31, 2020 48.67%
Sep 30, 2020 14.65%
Jun 30, 2020 54.39%
Mar 31, 2020 12.94%
Dec 31, 2019 0.93%
Sep 30, 2019 7.85%
Jun 30, 2019 -3.08%
Mar 31, 2019 -17.69%
Dec 31, 2018 -796.27%
Sep 30, 2018 1,109.94%
Jun 30, 2018 -837.40%
Mar 31, 2018 -984.91%
Dec 31, 2017 -711.83%
Sep 30, 2017 -797.66%
Jun 30, 2017 -826.01%
Mar 31, 2017 -909.90%
Dec 31, 2016 -676.94%
Sep 30, 2016 -889.09%
Jun 30, 2016 -816.12%
Mar 31, 2016 -850.72%
Dec 31, 2015 -6.99%
Sep 30, 2015 -2.60%
Jun 30, 2015 -4.88%
Mar 31, 2015 -2.74%
Dec 31, 2014 -9.26%
Sep 30, 2014 -0.48%
Jun 30, 2014 -0.94%
Mar 31, 2014 -3.81%
Dec 31, 2013 -7.97%
Sep 30, 2013 -8.80%